Cargando…

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

BACKGROUND: Tumor immune cells influence the efficacy of immune-checkpoint inhibitors (ICIs) and many efforts aim at identifying features of tumor immune microenvironment able to predict benefit from ICIs in proficient mismatch repair (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moretto, Roberto, Rossini, Daniele, Catteau, Aurélie, Antoniotti, Carlotta, Giordano, Mirella, Boccaccino, Alessandra, Ugolini, Clara, Proietti, Agnese, Conca, Veronica, Kassambara, Alboukadel, Pietrantonio, Filippo, Salvatore, Lisa, Lonardi, Sara, Tamberi, Stefano, Tamburini, Emiliano, Poma, Anello Marcello, Fieschi, Jacques, Fontanini, Gabriella, Masi, Gianluca, Galon, Jérôme, Cremolini, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Immunotherapy Biomarkers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124320/ https://www.ncbi.nlm.nih.gov/pubmed/37085190 http://dx.doi.org/10.1136/jitc-2022-006633

Ejemplares similares

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
por: Antoniotti, Carlotta, et al.
Publicado: (2020)

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
por: Borelli, B., et al.
Publicado: (2021)

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO
por: Rossini, Daniele, et al.
Publicado: (2022)

Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring
por: Boquet, Isabelle, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Mismatch Repair Proficient/Microsatellite Stable Metastatic Colorectal Cancer Patients: Insights from the AtezoTRIBE and MAYA Trials
por: Germani, Marco Maria, et al.
Publicado: (2021)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
por: Hijazi, Assia, et al.
Publicado: (2023)

Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients
por: Fiacchini, Giacomo, et al.
Publicado: (2022)

Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
por: Rossini, D., et al.
Publicado: (2021)

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
por: Poma, Anello Marcello, et al.
Publicado: (2018)

Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms
por: Alì, Greta, et al.
Publicado: (2021)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers
por: Bruno, Rossella, et al.
Publicado: (2022)

Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer
por: Ghiringhelli, François, et al.
Publicado: (2023)

Predictive Biomarkers in Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2022)

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
por: Fucà, Giovanni, et al.
Publicado: (2020)

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Chilling requirement of Ribes cultivars
por: Jones, Hamlyn G., et al.
Publicado: (2015)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy
por: Randon, Giovanni, et al.
Publicado: (2022)

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value
por: Viziteu, Elena, et al.
Publicado: (2016)

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
por: Devin, Julie, et al.
Publicado: (2019)

Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
por: Boccaccino, A., et al.
Publicado: (2022)

Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study
por: Cremolini, Chiara, et al.
Publicado: (2017)

Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
por: Dell’Aquila, E., et al.
Publicado: (2022)

Complete chloroplast genome assembly and phylogenetic analysis of blackcurrant (Ribes nigrum), red and white currant (Ribes rubrum), and gooseberry (Ribes uva-crispa) provide new insights into the phylogeny of Grossulariaceae
por: Sun, Xinyu, et al.
Publicado: (2023)

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center
por: Vignali, Paola, et al.
Publicado: (2022)

Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
por: Proietti, Agnese, et al.
Publicado: (2023)

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer
por: Borelli, Beatrice, et al.
Publicado: (2018)

A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2017)

Molecular Genetics of Follicular-Derived Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2021)

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
por: Cremolini, Chiara, et al.
Publicado: (2017)

Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO
por: Rossini, Daniele, et al.
Publicado: (2020)

Festschrift en honor de Emilio Ribes /
Publicado: (2020)

Festschrift en honor a Emilio Ribes
por: Alcaraz, Víctor Manuel
Publicado: (2021)

On Dilatation of the Cervix by Champetier De Ribes's Bag
por: Haultain, F. W. N.
Publicado: (1894)

Dilatation of the Cervix by Champetier de Ribes's Bag
por: Haultain, F. W. N.
Publicado: (1894)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
por: Marmorino, Federica, et al.
Publicado: (2020)

Emilio Ribes Iñesta : una historia de proyectos institucionales de identidad disciplinaria e innovación educativa /
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9s7788iqt70pbo1iih967pbjdp